Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/1998
12/09/1998CN1201369A Stimulation of cell-mediated immune responses by targeted particulated genetic immunization
12/09/1998CA2231015A1 Novel compounds
12/08/1998US5847112 Process for making capsular polysaccharides from Streptococcus pneumoniae
12/08/1998US5847101 Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide
12/08/1998US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998US5846948 Herpes simplex virus ORF P is a repressor of viral protein synthesis
12/08/1998US5846946 Compositions and methods for administering Borrelia DNA
12/08/1998US5846826 Isolated cytolytic T cell line specific to complexes of HLA-B44 molecules and specific nonapeptides
12/08/1998US5846825 Feline derived T-cell lines for producing FIV
12/08/1998US5846806 Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
12/08/1998US5846805 Culture of swine infertility and respiratory syndrome virus in simian cells
12/08/1998US5846772 Two component signal transduction system response regulator polynucleotides of Staphylococcus aureus
12/08/1998US5846751 Test kits and methods for detecting H. pylori
12/08/1998US5846741 Boron neutron capture therapy using pre-targeting methods
12/08/1998US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
12/08/1998US5846735 Hepatitis C virus Fc-binding function
12/08/1998US5846733 Structural phosphoprotein (PP150) of human cytomegalovirus, and the preparation and use thereof
12/08/1998US5846725 Methods for identifying cisplatin resistant tumor cells
12/08/1998US5846707 Herpes simplex virus as a vector
12/08/1998US5846565 Controlled local delivery of chemotherapeutic agents for treating solid tumors
12/08/1998US5846559 Skin patch for use in contact immunotherapy
12/08/1998US5846547 Streptococcal C5a peptidase vaccine
12/08/1998US5846546 Preparation and use of viral vectors for mixed envelope protein immunogenic composition against human immunodeficiency viruses
12/08/1998US5846545 Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
12/08/1998US5846543 Bovine mastitis treatment
12/08/1998US5846540 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
12/08/1998US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
12/08/1998US5846527 Continuous cell line and vaccine against avian coccidia
12/08/1998CA2094600C Immunogenic complexes, in particular iscoms
12/08/1998CA2073180C Therapeutic uses of melanin
12/08/1998CA2055598C Feline calicivirus gene
12/08/1998CA1340172C Diagnostics and vaccines for mycobacteria in public health, medical, andveterinary practise
12/08/1998CA1340167C Method for radiolabeling proteins
12/06/1998CA2207246A1 Vaccine development
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233590A1 Novel compounds
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054343A1 Anti-cancer vaccine
12/03/1998WO1998054324A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054296A1 Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
12/03/1998WO1998054226A1 Processes for production of immunoglobulin a in milk
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998WO1998054215A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
12/03/1998WO1998054213A2 Neurotrophic factor receptors
12/03/1998WO1998053854A1 Antigen delivery system
12/03/1998WO1998053851A1 Laft mutants of pathogenic gram-negative bacteria
12/03/1998WO1998053843A1 INHIBITION OF ANTIGEN-SPECIFIC IgE PRODUCTION BY ANTIGEN COUPLED TO MEMBRANE IgE PETIDE
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053799A2 Immunogenic compositions
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998035684A3 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998DE19719652A1 Use of tissue factor
12/03/1998CA2291698A1 Osf2/cbfa1 compositions and methods of use
12/03/1998CA2291487A1 Processes for production of immunoglobulin a in milk
12/03/1998CA2291278A1 Antigen delivery system
12/03/1998CA2290954A1 Human multiple endocrine neoplasia type 1 protein
12/03/1998CA2290943A1 New human dp1 homolog
12/03/1998CA2288971A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881297A2 Histidine kinase
12/02/1998EP0881296A2 Histidine kinase
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881290A2 Neurotransmitter transporter HPDDV78
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0881286A2 Histidine kinase
12/02/1998EP0881285A1 D-Alanine transferase
12/02/1998EP0881231A2 HCV peptide-antigens and a method of testing for the hepatitis C virus
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880589A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880588A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
12/02/1998EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use
12/02/1998EP0880543A1 Tick (ixodes scapularis) vector saliva-induced lyme disease spirochete (borrelia burgdorferi) antigens as vaccine candidates
12/02/1998EP0880361A1 Immunogenic detoxified mutants of cholera toxin
12/02/1998EP0880360A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
12/02/1998EP0599913B1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same
12/02/1998EP0597838B1 Vaccine compositions
12/02/1998EP0527785B1 Improvements relating to the detection of viruses
12/02/1998CN1200763A New adhesion from helicobactor pylori
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
12/02/1998CN1200675A 流感疫苗 Influenza vaccination
12/02/1998CN1200668A Liposomes contg. particulate materials
12/02/1998CN1040946C Method for preparing orally administering agent to and through the peyer's patch
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844094 Target binding polypeptide
12/01/1998US5844093 Anti-EGFR single-chain Fvs and anti-EGFR antibodies
12/01/1998US5844092 Human TRK receptors and neurotrophic factor inhibitors
12/01/1998US5844091 Antibody having binding specificity for human ouabain
12/01/1998US5844075 Melanoma antigens and their use in diagnostic and therapeutic methods
12/01/1998US5844072 Antibiotic cryptdin peptides and methods of their use
12/01/1998US5843913 Nucleic acid respiratory syncytial virus vaccines
12/01/1998US5843894 Methods for reduced renal uptake of antibody fragments
12/01/1998US5843886 Method of treating or preventing Type 1 diabetes by oral administration of insulin
12/01/1998US5843779 Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
12/01/1998US5843775 Human dorsal tissue affecting factor (noggin) and nucleic acids encoding same
12/01/1998US5843774 Polypeptides for promoting cell attachment
1 ... 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 ... 1823